Complete Filing Data
Entrada Therapeutics, Inc. reported Stockholders Equity of $306.13 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Entrada Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$143.8M | $65.6M | -$6.7M | -$94.6M | -$51.2M | -$26.5M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $695.0K | -$238.0K | $2.3M | -$2.1M | $0.00 | |
| Research And Development Expense | $142.3M | $125.3M | $99.9M | $66.6M | $35.9M | $21.1M |
| Other Nonoperating Income Expense | $15.1M | $19.5M | $15.2M | $2.6M | -$31.0K | $144.0K |
| Operating Income Loss | -$157.9M | $47.0M | -$3.2M | -$97.2M | -$51.1M | -$26.7M |
| Operating Expenses | $183.3M | $163.8M | $132.2M | $97.2M | $51.1M | $26.7M |
| General And Administrative Expense | $41.1M | $38.5M | $32.3M | $30.6M | $15.2M | $5.6M |
| Comprehensive Income Net Of Tax | -$143.1M | $65.4M | -$4.4M | -$96.7M | -$51.2M | |
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $695.0K | -$238.0K | $2.3M | |||
| Income Tax Expense Benefit | $924.0K | $859.0K | $18.7M | $0.00 | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $25.4M | $210.8M | $129.0M | |||
| Deferred Revenue Current | $342.0K | $13.7M | $132.3M | $0.00 | ||
| Deferred Revenue | $0.00 | $6.5M | $7.7M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$44.1M | -$43.1M | -$17.3M | -$14.0M | $55.0M | $23.5M | $35.5M | -$25.9M | -$6.7M | -$25.1M | -$23.2M | -$21.7M | -$14.4M | -$9.9M | -$8.4M | -$7.0M | -$6.2M | -$4.7M |
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | $221.0K | -$37.0K | $480.0K | $1.3M | -$83.0K | -$441.0K | $509.0K | -$363.0K | $1.4M | -$482.0K | -$730.0K | -$1.5M | $0.00 | $0.00 | $0.00 | |||
| Research And Development Expense | $38.4M | $37.9M | $32.1M | $31.3M | $32.0M | $28.6M | $22.2M | $26.3M | $23.1M | $19.0M | $16.2M | $15.7M | $10.5M | $6.8M | $6.2M | $5.7M | ||
| Other Nonoperating Income Expense | $3.6M | $3.9M | $4.4M | $5.8M | $4.4M | $4.2M | $4.1M | $4.2M | $2.7M | $799.0K | $403.0K | $480.0K | -$66.0K | $9.0K | $13.0K | -$17.0K | ||
| Operating Income Loss | -$47.1M | -$46.8M | -$21.8M | -$21.7M | $53.4M | $21.1M | $14.0M | -$16.3M | -$5.8M | -$25.9M | -$23.6M | -$22.2M | -$14.4M | -$9.9M | -$8.4M | -$7.0M | ||
| Operating Expenses | $48.7M | $48.8M | $42.3M | $41.2M | $41.3M | $38.0M | $29.7M | $34.5M | $31.0M | $25.9M | $23.6M | $22.2M | $14.4M | $9.9M | $8.4M | $7.0M | ||
| General And Administrative Expense | $10.3M | $10.9M | $10.3M | $10.0M | $9.2M | $9.4M | $7.5M | $8.2M | $7.9M | $7.0M | $7.3M | $6.4M | $3.9M | $3.1M | $2.2M | $1.3M | ||
| Comprehensive Income Net Of Tax | -$43.9M | -$43.1M | -$16.9M | -$12.7M | $54.9M | $23.1M | $36.0M | -$26.3M | -$5.3M | -$25.6M | -$23.9M | -$23.2M | -$14.4M | -$9.9M | -$8.4M | |||
| Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent | $221.0K | -$37.0K | $480.0K | $1.3M | -$83.0K | -$441.0K | $509.0K | -$363.0K | $1.4M | -$482.0K | -$730.0K | -$1.5M | $0.00 | $0.00 | $0.00 | |||
| Income Tax Expense Benefit | $654.0K | $178.0K | $0.00 | -$1.9M | $2.8M | $1.8M | -$17.4M | $13.8M | $3.6M | $0.00 | $0.00 | $0.00 | ||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $1.6M | $2.0M | $20.6M | $19.6M | $94.7M | $59.1M | $43.7M | $18.2M | $25.3M | $0.00 | $0.00 | $0.00 | ||||||
| Deferred Revenue Current | $351.0K | $689.0K | $1.4M | $45.9M | $60.5M | $148.5M | $148.4M | $101.6M | $122.3M | |||||||||
| Deferred Revenue | $113.0K | $194.0K | $301.0K | $8.0M | $10.4M | $9.4M | $10.5M | $95.5M | $89.2M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $306.1M | $428.7M | $242.4M | $212.6M | $298.7M | -$41.5M | -$15.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $94.3M | $105.2M | $71.6M | $49.1M | $291.1M | $39.0M | $16.8M |
| Retained Earnings Accumulated Deficit | -$273.1M | -$129.3M | -$195.0M | -$188.3M | -$93.7M | -$42.5M | |
| Property Plant And Equipment Net | $7.3M | $10.9M | $11.2M | $7.7M | $6.3M | $3.0M | |
| Prepaid Expense And Other Assets Current | $8.7M | $16.4M | $11.9M | $21.2M | $7.6M | $904.0K | |
| Other Assets Noncurrent | $70.0K | $284.0K | $2.8M | $5.2M | $872.0K | $541.0K | |
| Liabilities Current | $24.5M | $39.5M | $158.8M | $22.0M | $6.7M | $3.4M | |
| Liabilities And Stockholders Equity | $377.4M | $526.3M | $469.2M | $252.1M | $305.8M | $43.5M | |
| Liabilities | $71.2M | $97.6M | $226.8M | $39.5M | $7.1M | $3.4M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$10.8M | $33.6M | $22.4M | -$242.0M | $252.0M | $22.2M | |
| Cash And Cash Equivalents At Carrying Value | $90.4M | $101.2M | $67.6M | $45.2M | $291.1M | $39.0M | |
| Assets Current | $306.3M | $440.0M | $369.8M | $209.9M | $298.7M | $39.9M | |
| Assets | $377.4M | $526.3M | $469.2M | $252.1M | $305.8M | $43.5M | |
| Accrued Liabilities Current | $17.7M | $13.3M | $11.3M | $7.6M | $6.0M | $1.8M | |
| Accounts Payable Current | $2.3M | $4.3M | $3.3M | $6.0M | $706.0K | $1.6M | |
| Common Stock Value | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | ||
| Restricted Cash Noncurrent | $3.3M | $4.0M | $4.0M | $4.0M | $0.00 | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $652.0K | -$43.0K | $195.0K | -$2.1M | $0.00 | ||
| Accretion Amortization Of Discounts And Premiums Investments | $3.7M | $10.0M | $5.8M | -$151.0K | $0.00 | ||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $81.7M | $31.8M | |||
| Operating Lease Liability Current | $4.1M | $7.6M | $7.9M | $8.4M | $0.00 | ||
| Operating Lease Right Of Use Asset | $60.5M | $71.1M | $81.5M | $25.3M | |||
| Operating Lease Liability Noncurrent | $46.8M | $51.6M | $60.3M | $17.5M | |||
| Debt Securities Available For Sale Excluding Accrued Interest | $205.3M | $318.8M | $284.4M | $143.6M | $0.00 | ||
| Transfer Of Deposits For Equipment From Operating To Investing Cash Flows | $0.00 | $617.0K | $495.0K | $0.00 | |||
| Contract With Customer Receivable After Allowance For Credit Loss | $1.2M | $3.7M | $5.9M | $0.00 | |||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $77.6M | $0.00 | ||||
| Taxes Payable Current | $0.00 | $667.0K | $4.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $340.7M | $379.5M | $417.3M | $422.4M | $429.9M | $269.4M | $246.7M | $206.9M | $229.6M | $233.2M | $256.0M | $277.4M | -$72.6M | -$59.0M | -$49.7M | -$33.0M | -$26.1M | -$20.1M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $97.2M | $76.4M | $71.8M | $82.0M | $189.2M | $72.4M | $55.8M | $83.7M | $231.6M | $57.3M | $94.8M | $88.6M | $122.2M | $136.9M | $146.2M | $47.0M | |||
| Retained Earnings Accumulated Deficit | -$233.9M | -$189.8M | -$146.7M | -$130.5M | -$116.4M | -$171.5M | -$185.4M | -$220.9M | -$195.0M | -$163.7M | -$138.5M | -$115.3M | -$75.2M | ||||||
| Property Plant And Equipment Net | $8.4M | $9.8M | $10.7M | $10.8M | $11.3M | $11.0M | $11.0M | $11.0M | $9.4M | $7.4M | $7.8M | $7.2M | $5.9M | ||||||
| Prepaid Expense And Other Assets Current | $10.2M | $14.0M | $18.6M | $13.4M | $12.1M | $9.2M | $24.4M | $9.7M | $16.2M | $19.2M | $9.6M | $8.8M | $1.4M | ||||||
| Other Assets Noncurrent | $163.0K | $199.0K | $239.0K | $746.0K | $747.0K | $2.8M | $3.0M | $538.0K | $13.8M | $954.0K | $875.0K | $1.4M | $3.0M | ||||||
| Liabilities Current | $24.0M | $19.8M | $18.4M | $70.6M | $85.8M | $173.9M | $165.4M | $125.9M | $147.6M | $21.6M | $18.1M | $15.4M | $7.2M | ||||||
| Liabilities And Stockholders Equity | $412.9M | $448.8M | $486.5M | $554.6M | $582.0M | $510.8M | $485.0M | $494.0M | $475.6M | $274.5M | $295.9M | $316.7M | $132.4M | ||||||
| Liabilities | $72.2M | $69.3M | $69.2M | $132.1M | $152.0M | $241.5M | $238.4M | $287.1M | $246.0M | $41.2M | $39.9M | $39.3M | $7.5M | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$33.4M | $834.0K | $182.5M | -$202.5M | $107.1M | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $93.3M | $72.5M | $67.8M | $78.0M | $185.3M | $68.4M | $51.9M | $79.7M | $227.6M | $53.3M | $90.9M | $84.6M | $122.2M | ||||||
| Assets Current | $338.3M | $369.1M | $403.2M | $465.3M | $489.5M | $414.2M | $383.0M | $390.2M | $434.1M | $234.7M | $253.9M | $272.7M | $123.5M | ||||||
| Assets | $412.9M | $448.8M | $486.5M | $554.6M | $582.0M | $510.8M | $485.0M | $494.0M | $475.6M | $274.5M | $295.9M | $316.7M | $132.4M | ||||||
| Accrued Liabilities Current | $15.5M | $11.8M | $7.6M | $13.4M | $11.0M | $8.8M | $9.6M | $7.1M | $11.7M | $12.0M | $5.3M | $4.5M | $4.9M | ||||||
| Accounts Payable Current | $3.2M | $1.9M | $2.2M | $1.3M | $1.6M | $2.5M | $752.0K | $2.4M | $6.5M | $1.3M | $4.6M | $2.9M | $2.3M | ||||||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |||||||
| Restricted Cash Noncurrent | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | $4.0M | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $621.0K | $400.0K | $437.0K | $972.0K | -$329.0K | -$246.0K | -$496.0K | -$1.0M | -$642.0K | -$2.7M | -$2.3M | -$1.5M | |||||||
| Accretion Amortization Of Discounts And Premiums Investments | $1.3M | $2.0M | $237.0K | -$142.0K | $0.00 | ||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | $0.00 | $0.00 | $0.00 | $197.5M | $197.5M | $197.5M | $81.7M | $56.8M | $56.8M | ||||||||||
| Operating Lease Liability Current | $4.4M | $5.5M | $6.5M | $7.7M | $8.6M | $8.3M | $6.6M | $7.4M | $7.1M | $8.3M | $8.1M | $8.0M | |||||||
| Operating Lease Right Of Use Asset | $62.1M | $65.7M | $68.4M | $73.8M | $76.4M | $79.0M | $84.0M | $88.3M | $14.2M | $27.4M | $29.4M | $31.4M | $0.00 | ||||||
| Operating Lease Liability Noncurrent | $48.1M | $49.3M | $50.5M | $53.6M | $55.9M | $58.1M | $62.4M | $65.6M | $9.1M | $19.7M | $21.8M | $23.9M | $0.00 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest | $233.6M | $281.5M | $314.7M | $371.3M | $284.5M | $259.0M | $301.7M | $297.0M | $184.0M | ||||||||||
| Transfer Of Deposits For Equipment From Operating To Investing Cash Flows | $0.00 | $617.0K | $495.0K | $0.00 | |||||||||||||||
| Contract With Customer Receivable After Allowance For Credit Loss | $1.2M | $1.2M | $2.0M | $2.6M | $7.7M | $77.5M | $5.0M | $3.7M | $6.3M | ||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $33.0M | $0.00 | ||||||||||||||||
| Taxes Payable Current | $620.0K | $0.00 | $802.0K | $2.3M | $4.1M | $5.9M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $19.6M | $17.9M | $13.1M | $9.9M | $2.5M | $325.0K |
| Payments To Acquire Property Plant And Equipment | $1.0M | $3.2M | $5.6M | $2.9M | $4.6M | $2.3M |
| Net Cash Provided By Used In Operating Activities | -$128.5M | -$41.6M | $139.8M | -$93.8M | -$50.9M | -$25.6M |
| Net Cash Provided By Used In Investing Activities | $116.8M | -$27.8M | -$138.4M | -$148.7M | -$4.6M | -$2.3M |
| Net Cash Provided By Used In Financing Activities | $887.0K | $103.0M | $21.0M | $479.0K | $307.5M | $50.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$7.6M | $4.4M | -$8.6M | $14.0M | $6.7M | $311.0K |
| Increase Decrease In Other Noncurrent Assets | -$214.0K | -$2.5M | $11.6M | $4.3M | $331.0K | $541.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $4.7M | $1.7M | $3.8M | $1.8M | $4.0M | $578.0K |
| Increase Decrease In Accounts Payable Trade | -$1.8M | $991.0K | -$2.8M | $5.3M | -$715.0K | $631.0K |
| Proceeds From Stock Options Exercised | $425.0K | $2.8M | $443.0K | $284.0K | $410.0K | $213.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $259.5M | $413.1M | $274.4M | $76.2M | $0.00 | |
| Payments To Acquire Marketable Securities | $141.6M | $437.7M | $407.2M | $222.0M | $0.00 | |
| Increase Decrease In Operating Lease Right Of Use Assets | -$10.7M | -$10.4M | -$12.0M | -$7.7M | ||
| Increase Decrease In Operating Lease Liability | -$8.3M | -$9.0M | -$11.9M | -$7.5M | ||
| Increase Decrease In Long Term Receivables Current | -$2.5M | -$2.2M | $5.9M | $0.00 | ||
| Increase Decrease In Deferred Revenue | -$19.8M | -$119.8M | $140.0M | $0.00 | ||
| Increase Decrease In Accrued Income Taxes Payable | -$667.0K | -$3.4M | $4.0M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $5.1M | $3.7M | $2.8M | $1.8M | $164.0K |
| Payments To Acquire Property Plant And Equipment | $1.1M | $838.0K | $1.7M | $594.0K | $908.0K |
| Net Cash Provided By Used In Operating Activities | -$38.5M | -$25.5M | $203.4M | -$21.0M | -$8.3M |
| Net Cash Provided By Used In Investing Activities | $4.8M | $26.1M | -$40.4M | -$181.5M | -$908.0K |
| Net Cash Provided By Used In Financing Activities | $350.0K | $206.0K | $19.5M | $50.0K | $116.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $2.3M | -$2.7M | -$4.3M | $1.7M | $66.0K |
| Increase Decrease In Other Noncurrent Assets | -$45.0K | -$28.0K | $8.6M | $562.0K | -$23.0K |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | -$5.5M | -$2.5M | $4.1M | -$1.5M | -$510.0K |
| Increase Decrease In Accounts Payable Trade | -$1.9M | -$655.0K | $534.0K | $2.1M | -$268.0K |
| Proceeds From Stock Options Exercised | $350.0K | $206.0K | $129.0K | $50.0K | $29.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $85.9M | $123.9M | $63.0M | $1.7M | $0.00 |
| Payments To Acquire Marketable Securities | $80.0M | $96.9M | $101.8M | $182.7M | $0.00 |
| Increase Decrease In Operating Lease Right Of Use Assets | -$2.7M | -$2.5M | -$3.3M | -$1.6M | $0.00 |
| Increase Decrease In Operating Lease Liability | -$2.2M | -$1.8M | -$2.0M | -$1.5M | $0.00 |
| Increase Decrease In Long Term Receivables Current | -$1.6M | $71.6M | $6.3M | $0.00 | |
| Increase Decrease In Deferred Revenue | -$18.5M | $17.9M | $211.6M | $0.00 | |
| Increase Decrease In Accrued Income Taxes Payable | $135.0K | $1.8M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 41.4M | 37.3M | 33.1M | 31.3M | 6.3M | 1.1M | |
| Weighted Average Number Of Diluted Shares Outstanding | 41.4M | 39.0M | 33.1M | 31.3M | 6.3M | 1.1M | |
| Earnings Per Share Diluted | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 | $-24.00 | |
| Earnings Per Share Basic | $-3.47 | $1.76 | $-0.20 | $-3.02 | $-8.16 | $-24.00 | |
| Common Stock Shares Outstanding | 38.3M | 37.6M | 33.4M | 31.4M | 31.2M | 1.2M | |
| Common Stock Shares Issued | 38.3M | 37.6M | 33.5M | 31.4M | 31.3M | 1.3M | |
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 113.3M | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 85.3M | 37.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 41.5M | 41.3M | 41.1M | 40.6M | 34.2M | 33.5M | 33.3M | 33.2M | 32.4M | 31.3M | 31.3M | 31.2M | 1.5M | 1.3M | 1.3M | 1.1M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 41.5M | 41.3M | 41.1M | 40.6M | 35.5M | 34.8M | 34.8M | 33.2M | 32.4M | 31.3M | 31.3M | 31.2M | 1.5M | 1.3M | 1.3M | 1.1M | ||
| Earnings Per Share Diluted | $-1.06 | $-1.04 | $-0.42 | $-0.35 | $1.55 | $0.68 | $1.02 | $-0.78 | $-0.21 | $-0.80 | $-0.74 | $-0.69 | $-9.78 | $-7.56 | $-6.67 | $-6.13 | ||
| Earnings Per Share Basic | $-1.06 | $-1.04 | $-0.42 | $-0.35 | $1.61 | $0.70 | $1.07 | $-0.78 | $-0.21 | $-0.80 | $-0.74 | $-0.69 | $-9.78 | $-7.56 | $-6.67 | $-6.13 | ||
| Common Stock Shares Outstanding | 38.2M | 38.0M | 37.9M | 37.4M | 37.2M | 33.6M | 33.3M | 33.2M | 33.1M | 31.3M | 31.3M | 31.3M | 1.5M | |||||
| Common Stock Shares Issued | 38.2M | 38.0M | 38.0M | 37.4M | 37.2M | 33.6M | 33.4M | 33.2M | 33.2M | 31.4M | 31.4M | 31.4M | 1.7M | |||||
| Common Stock Shares Authorized | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 172.0M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 138.8M | 138.8M | 138.8M | 85.3M | 61.3M | 61.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $19.6M | $17.9M | $13.1M | $9.9M | $2.5M | $325.0K |
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $14.0K | $51.0K | $91.0K | $135.0K | $250.0K | $11.0K |
| Stock Issued During Period Value Stock Options Exercised | $425.0K | $2.8M | $1.2M | $195.0K | $410.0K | $214.0K |
| Interest And Other Income Expense Net | $15.1M | $19.5M | $15.2M | $2.6M | -$31.0K | $144.0K |
| Depreciation | $4.1M | $3.8M | $2.8M | $1.9M | $1.1M | $326.0K |
| Vesting Of Options Early Exercised Subject To Repurchase | $14.0K | $51.0K | $91.0K | $135.0K | $250.0K | $11.0K |
| Income Loss Attributable To Parent | -$142.8M | $66.5M | $12.1M | -$94.6M | ||
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $560.0K | $208.0K | $88.0K | $155.0K | $320.0K |
| Additional Paid In Capital | $578.6M | $558.1M | $437.1M | $402.9M | $392.4M | $1.0M |
| Stock Issued During Period Shares Vesting Of Early Exercised Stock Options | 0.00 | 1.7K | 14.7K | 53.7K | 111.8K | |
| Stock Issued During Period Value Employee Stock Purchase Plan | $462.0K | $574.0K | $443.0K | $284.0K | ||
| Stock Issued During Period Value New Issues | $99.6M | $19.4M | $190.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $5.1M | $5.0M | $5.1M | $4.9M | $4.6M | $3.7M | $3.4M | $3.1M | $2.8M | $2.7M | $2.5M | $1.8M | $577.0K | $326.0K | $164.0K | $75.0K | $74.0K | $78.0K |
| Stock Issued During Period Value Vesting Of Early Exercised Stock Options | $14.0K | $12.0K | $13.0K | $13.0K | $21.0K | $25.0K | $26.0K | $33.0K | $34.0K | $35.0K | $170.0K | $18.0K | $8.0K | $3.0K | $3.0K | $3.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $8.0K | $20.0K | $350.0K | $381.0K | $1.1M | $206.0K | $368.0K | $257.0K | $129.0K | $60.0K | $11.0K | $50.0K | $106.0K | $212.0K | $29.0K | $83.0K | $1.0K | |
| Interest And Other Income Expense Net | $3.6M | $3.9M | $4.4M | $5.8M | $4.4M | $4.2M | $4.1M | $4.2M | $2.7M | $799.0K | $403.0K | $480.0K | -$66.0K | $9.0K | $13.0K | -$17.0K | ||
| Depreciation | $1.2M | $1.1M | $946.0K | $900.0K | $900.0K | $934.0K | $800.0K | $700.0K | $541.0K | $500.0K | $500.0K | $390.0K | $300.0K | $300.0K | $199.0K | $100.0K | ||
| Vesting Of Options Early Exercised Subject To Repurchase | $14.0K | $13.0K | $26.0K | $35.0K | $8.0K | |||||||||||||
| Income Loss Attributable To Parent | -$43.5M | -$42.9M | -$17.3M | -$15.9M | $57.8M | $25.3M | $18.1M | -$12.1M | -$3.1M | -$25.1M | -$23.2M | -$21.7M | ||||||
| Capital Expenditures Incurred But Not Yet Paid | $108.0K | $115.0K | $57.0K | $391.0K | $462.0K | |||||||||||||
| Additional Paid In Capital | $574.0M | $568.9M | $563.5M | $551.9M | $546.7M | $441.1M | $432.6M | $428.8M | $425.2M | $399.6M | $396.8M | $394.3M | $2.6M | |||||
| Stock Issued During Period Shares Vesting Of Early Exercised Stock Options | 0.00 | 11.3K | 43.6K | 96.5K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $317.0K | $263.0K | $186.0K | |||||||||||||||
| Stock Issued During Period Value New Issues | $99.6M | $19.4M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.